Morning Movers: Viridian surges following THRIVE trial data readout

Check out this morning’s top movers from around Wall Street, compiled by The Fly.

HIGHER –

• Viridian Therapeutics (VRDN) up 16% after announcing its THRIVE trial met the primary and all secondary endpoints at 15 weeks after five infusions of veligrotug, showing highly statistically significant improvements on all of the measured signs and symptoms of TED
• Southwest (LUV) up 1% after reporting the next phase of the board’s transformation, including significant ongoing refreshment and the announcement that chairman Gary Kelly will retire in 2025

UP AFTER EARNINGS –

• Cognyte (CGNT) up 8%
• Mission Produce (AVO) up 17%
• Oracle (ORCL) up 8%

DOWN AFTER EARNINGS –

• Rubrik (RBRK) down 5%

LOWER –

• Silo Pharma (SILO) down 13% after reporting the completion of a pre-Investigational new drug meeting with the FDA regarding the company’s development plan for SPC-15
• Apple (AAPL) down 1% after the European Union’s Court of Justice set aside the judgment of the General Court concerning tax rulings issued by Ireland in favor of Apple